SCHEMBL13613615

SCHEMBL13613615

O=C(NCCc1ccccc1)Nc1cccc2c1CC(O)CC2

nearest known ligand 0.57

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 20/20 0.57
OPRM1 P35372 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13613682 0.90 TRPV1 (0.52) TRPV1
SCHEMBL4344935 0.90 TRPV1 (0.52) TRPV1
SCHEMBL13613685 0.90 TRPV1 (0.52) TRPV1
SCHEMBL13613606 0.88 TRPV1 (0.59) TRPV1OPRM1
SCHEMBL4336906 0.87 TRPV1 (0.54) TRPV1OPRM1
SCHEMBL13627960 0.86 TRPV1 (0.46) TRPV1OPRM1
SCHEMBL4340575 0.85 TRPV1 (0.54) TRPV1OPRM1
SCHEMBL14278339 0.83 TRPV1 (0.53) TRPV1OPRM1
SCHEMBL13613616 0.82 TRPV1 (0.56) TRPV1OPRM1
SCHEMBL4336612 0.81 TRPV1 (0.64) TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612113-B2 Such as N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-(7-hydroxy-5,6,7,8-tetrahydro-1-naphthalenyl)urea; vanilloid receptor antagonists; for treatment of urge urinary incontinence, overactive bladder, chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, COPD XENTION LIMITED (GB) 2009-11-03 US disclosed
US-7612113-B2 Such as N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-(7-hydroxy-5,6,7,8-tetrahydro-1-naphthalenyl)urea; vanilloid receptor antagonists; for treatment of urge urinary incontinence, overactive bladder, chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, COPD XENTION LIMITED (GB) 2009-11-03 US disclosed
EP-1506167-B1 HYDROXY TETRAHYDRO-NAPHTHALENYLUREA DERIVATIVES BAYER HEALTHCARE AG (DE) 2007-08-29 EP disclosed